Naing, A., Wong, D. J., Infante, J. R., Korn, W. M., Aljumaily, R., Papadopoulos, K. P., Autio, K. A., Pant, S., Bauer, T. M., Drakaki, A., Daver, N. G., Hung, A., Ratti, N., McCauley, S., Van Vlasselaer, P., Verma, R., Ferry, D., Oft, M., Diab, A., Garon, E. B., & Tannir, N. M. (2019). pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial. Lancet oncology, 20(11), 1544–1555. http://access.bl.uk/ark:/81055/vdc_100094620722.0x000012